(Q34157008)

31 July 2017

title

High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. (English)

1 reference

31 July 2017

0 references

1 reference

6

Joachim Jankowski

1 reference

31 July 2017

Markus van der Giet

9

1 reference

ORCID Public Data File 2021

author name string

Markus Tölle

1

1 reference

31 July 2017

Tao Huang

2

1 reference

31 July 2017

Mirjam Schuchardt

3

1 reference

31 July 2017

Vera Jankowski

4

1 reference

31 July 2017

Nicole Prüfer

5

1 reference

31 July 2017

Uwe J F Tietge

7

1 reference

31 July 2017

Walter Zidek

8

1 reference

31 July 2017

publication date

10 February 2012

1 reference

31 July 2017

published in

Cardiovascular Research

1 reference

31 July 2017

volume

94

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

154-162

1 reference

Antiinflammatory properties of HDL.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Clinical review: The evolving role of HDL in the treatment of high-risk patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Atherosclerosis regression and high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Apo A-I inhibits foam cell formation in Apo E-deficient mice after monocyte adherence to endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

High-density lipoproteins, inflammation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

High-density lipoprotein: a potent inhibitor of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Association between serum lipids and survival in hemodialysis patients and impact of race

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

High-density lipoprotein function recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Atherosclerosis in hemodialysis patients--the role of microinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Atherosclerosis in CKD: differences from the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

HDL-inflammatory index correlates with poor outcome in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The versatility of HDL: a crucial anti-inflammatory regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

HDL-associated lysosphingolipids inhibit NAD(P)H oxidase-dependent monocyte chemoattractant protein-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The role of chemokines in atherosclerosis: recent evidence from experimental models and population genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Modulation of atherogenesis by chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Lipid extraction of tissues with a low-toxicity solvent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Nonexpression of the Human Serum Amyloid A Three (SAA3) Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Uremia alters HDL composition and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

CD36 is a novel serum amyloid A (SAA) receptor mediating SAA binding and SAA-induced signaling in human and rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Is serum amyloid A an endogenous TLR4 agonist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Incentive-elicited mesolimbic activation and externalizing symptomatology in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

HDL remodeling during the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

SR-BI selective lipid uptake: subsequent metabolism of acute phase HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS089

21 January 2018

Identifiers

DOI

10.1093/CVR/CVS089

1 reference

31 July 2017

1 reference